Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?

Citation
Pal. Ashfield-watt et al., Folate, homocysteine, endothelial function and cardiovascular disease. What is the link?, BIOMED PHAR, 55(8), 2001, pp. 425-433
Citations number
54
Categorie Soggetti
Pharmacology & Toxicology
Journal title
BIOMEDICINE & PHARMACOTHERAPY
ISSN journal
07533322 → ACNP
Volume
55
Issue
8
Year of publication
2001
Pages
425 - 433
Database
ISI
SICI code
0753-3322(200110)55:8<425:FHEFAC>2.0.ZU;2-C
Abstract
Elevated plasma homocysteine concentrations are associated with an increase d risk of cardiovascular disease, but the relationship has not been proven to be causal. Folate is the strongest nutritional and pharmacological deter minant of plasma homocysteine concentrations, which also interact with the genetic variation in methylenetetrahydrofolate reductase (MTHFR). Endotheli al dysfunction due to reduced nitric oxide bioavailability is an early feat ure of vascular pathology. This can be assessed noninvasively by measuremen t of flow-mediated dilatation. Human studies on folic acid, homocysteine an d endothelial function are reported. It is proposed that folic acid in high doses may have beneficial effects on endothelial function, which are indep endent of homocysteine lowering. (C) 2001 editions scientifiques et medical es Elsevier SAS.